In parallel, the phosphorylation of NF-κB p65 and IκBα (inhibitor of NF-κB) was decreased following the administration of over-expressed miR-146a EVs, leading to inhibited secretion of TNF-α, IL-6 and IL-1β and thus ameliorated colitis (94). The gene discussed is IL6; the disease is colitis.